European Archives - Page 691 of 1000 - European Medical Journal

Continue
17 Mins
31 May 2018

Review of the 53rd International Liver Congress™ 2018

Bigger and better than ever before, this year’s dynamic EASL ILC was held in Paris, France from the 11th–15th April 2018. This historic city, long…
1 Mins
31 May 2018

Resolution of Ascites, Hepatic Encephalopathy, and Variceal Bleeding in Patients with Hepatitis C Virus and Decompensated Cirrhosis Who Received All-Oral Direct-Acting Antiviral Treatment

Worldwide, 185 million people are infected with the hepatitis C virus (HCV);1 approximately 12% of these individuals have manifestations of decompensated…
31 May 2018

ILC 2018 - Interview - Dr Dhiraj Tripathi

An interview with Dr Dhiraj Tripathi (Queen Elizabeth Hospital Birmingham, UK) at this year’s ILC congress held in Paris, France.
9 Mins
31 May 2018

Editor's Pick: Primary Hepatic Angiosarcoma: A Brief Review of the Literature

Primary hepatic angiosarcoma (HAS) is a liver tumour of endothelial cell origin. It is the most common malignant mesenchymal tumour of the liver…
1 Mins
31 May 2018

A Comparison of Renal Function Before and After Treatment of Chronic Hepatitis C Infection in Patients Who Achieve Sustained Virological Response with Direct-Acting Antivirals

Approximately 3 million people have chronic hepatitis C virus (HCV) infection in the USA. However, there are limited data with regard to the effect of…
2 Mins
31 May 2018

OPTIMIS: Real-World Data in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolisation: Second Interim Analysis

Transarterial chemoembolisation (TACE) is the most common treatment modality for hepatocellular carcinoma (HCC) worldwide, often used to treat cases…
8 Mins
31 May 2018

Acute Fatty Liver of Pregnancy: Better Understanding of Pathogenesis and Earlier Clinical Recognition Results in Improved Maternal Outcomes

Acute fatty liver of pregnancy (AFLP) is an uncommon disorder affecting women in late pregnancy. It is increasingly recognised as an important cause of…
2 Mins
31 May 2018

Acute Liver Failure: Time to Review Our Follow-Up Policy?

Acute liver failure (ALF) is a rare but serious clinical condition resulting from sudden, massive loss of hepatic parenchyma and metabolic functions.
9 Mins
31 May 2018

Targeting the Relaxin Pathway for Liver Disease Treatment

Hepatic fibrosis is a progressive disease with few treatment options outside of transplantation. Relaxin is a member of the insulin/relaxin superfamily…
2 Mins
31 May 2018

Monocyte-Derived Hepatocyte-Like Cells in Combination with Proteomics Identify a Potential Biomarker for Drug-Induced Liver Injury by Diclofenac

Drug-induced liver injury (DILI) is the leading cause of acute liver failure leading to death or requiring transplantation in the European Union (EU) and…